16-84398608-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014861.4(ATP2C2):​c.209G>T​(p.Cys70Phe) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,453,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 19/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

ATP2C2
NM_014861.4 missense, splice_region

Scores

19
Splicing: ADA: 0.001701
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.325

Publications

0 publications found
Variant links:
Genes affected
ATP2C2 (HGNC:29103): (ATPase secretory pathway Ca2+ transporting 2) Enables P-type calcium transporter activity and P-type manganese transporter activity. Predicted to be involved in calcium ion transmembrane transport; cellular calcium ion homeostasis; and manganese ion transport. Predicted to act upstream of or within mammary gland epithelium development; positive regulation of calcium ion import; and protein localization to plasma membrane. Predicted to be located in trans-Golgi network membrane. Predicted to be active in Golgi membrane; endoplasmic reticulum; and plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.20215356).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2C2NM_014861.4 linkc.209G>T p.Cys70Phe missense_variant, splice_region_variant Exon 2 of 27 ENST00000262429.9 NP_055676.3 O75185-1
ATP2C2NM_001286527.3 linkc.209G>T p.Cys70Phe missense_variant, splice_region_variant Exon 2 of 28 NP_001273456.2 O75185-3
ATP2C2XM_011523486.3 linkc.140G>T p.Cys47Phe missense_variant, splice_region_variant Exon 2 of 28 XP_011521788.1
ATP2C2XM_047434994.1 linkc.140G>T p.Cys47Phe missense_variant, splice_region_variant Exon 2 of 27 XP_047290950.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2C2ENST00000262429.9 linkc.209G>T p.Cys70Phe missense_variant, splice_region_variant Exon 2 of 27 1 NM_014861.4 ENSP00000262429.4 O75185-1
ATP2C2ENST00000416219.7 linkc.209G>T p.Cys70Phe missense_variant, splice_region_variant Exon 2 of 28 1 ENSP00000397925.2 O75185-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1453366
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
723272
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32866
American (AMR)
AF:
0.00
AC:
0
AN:
43214
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25906
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39372
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85266
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53276
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5724
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1107712
Other (OTH)
AF:
0.00
AC:
0
AN:
60030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 13, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.209G>T (p.C70F) alteration is located in exon 2 (coding exon 2) of the ATP2C2 gene. This alteration results from a G to T substitution at nucleotide position 209, causing the cysteine (C) at amino acid position 70 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
3.2
DANN
Benign
0.90
DEOGEN2
Benign
0.0093
T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.80
T;T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.20
T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
0.33
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.53
N;N
REVEL
Benign
0.21
Sift
Benign
0.030
D;D
Sift4G
Benign
0.12
T;T
Polyphen
0.0080
B;.
Vest4
0.24
MutPred
0.40
Loss of disorder (P = 0.3063);Loss of disorder (P = 0.3063);
MVP
0.37
ClinPred
0.11
T
GERP RS
-2.5
Varity_R
0.38
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0017
dbscSNV1_RF
Benign
0.24
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs953966300; hg19: chr16-84432214; API